Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pleural mesothelioma.

P Astoul1

  • 1Department of Pulmonology, Hôpital de La Conception, Marseille, France. pastoul@ap-hm.fr

Current Opinion in Pulmonary Medicine
|July 17, 1999
PubMed
Summary
This summary is machine-generated.

Malignant pleural mesothelioma (MPM) management is improving with new diagnostic markers and therapeutic strategies. Early diagnosis via thoracoscopy and multimodal treatments offer prolonged survival for carefully selected patients with this asbestos-related cancer.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Very long-term survival of a bronchial adenoid cystic-carcinoma treated bronchoscopically.

Respiratory medicine and research·2022
Same author

A novel pleural-bladder pump for the management of recurrent malignant pleural effusions: a feasibility animal study.

Respiratory research·2020
Same author

[Management of a tracheal adenoid cystic medico-surgical carcinoma].

Revue des maladies respiratoires·2018
Same author

[Trans-vocal cord prostheses - preliminary experience treating benign laryngotracheal stenosis in adults].

Revue des maladies respiratoires·2018
Same author

[Blue rubber bleb naevus syndrome involving the pleura].

Revue des maladies respiratoires·2018
Same author

In memoriam Christian Boutin (1933-2015).

Revue des maladies respiratoires·2016
Same journal

Toward precision imaging in interstitial lung disease: advances in quantitative imaging and artificial intelligence.

Current opinion in pulmonary medicine·2026
Same journal

Oxygen therapy in interstitial lung disease - navigating benefit and burden.

Current opinion in pulmonary medicine·2026
Same journal

Preclinical and clinical advances in pulmonary hypertension associated with systemic sclerosis.

Current opinion in pulmonary medicine·2026
Same journal

Advancing lung transplantation: current challenges and future directions.

Current opinion in pulmonary medicine·2026
Same journal

Association between upper airway obstruction and pulmonary hypertension in children with Down syndrome.

Current opinion in pulmonary medicine·2026
Same journal

Molecular mechanisms of environmental risk factors for interstitial lung disease.

Current opinion in pulmonary medicine·2026
See all related articles

Area of Science:

  • Oncology
  • Pulmonology
  • Pathology

Background:

  • Rising incidence of malignant pleural mesothelioma (MPM).
  • Established link between asbestos exposure and MPM pathogenesis.
  • Emerging promising therapeutic outcomes driving renewed interest in MPM management.

Purpose of the Study:

  • To review advancements in MPM diagnosis and treatment.
  • To highlight the importance of early diagnosis for effective management.
  • To discuss current therapeutic strategies and future research directions.

Main Methods:

  • Improved diagnostic accuracy using novel immunohistochemical markers.
  • Enhanced staging systems for patient stratification.
  • Endoscopic procedures like thoracoscopy for diagnosis and potential early intervention.

Related Experiment Videos

Main Results:

  • New markers improve specificity and sensitivity for MPM diagnosis on pleural biopsies.
  • Thoracoscopy enables early-stage diagnosis, crucial for treatment planning.
  • Multimodal management (surgery, radiotherapy, chemotherapy) shows prolonged survival in selected advanced MPM patients.

Conclusions:

  • Current diagnostic tools and staging systems facilitate better patient management.
  • Early diagnosis and enrollment in clinical protocols are key to improving outcomes.
  • Optimized multimodal therapeutic approaches are shifting the outlook for MPM patients from pessimistic to hopeful.